EGFR and breast carcinoma: genetically engineered EVs to achieve targeted delivery of let‐7a miRNA to epidermal growth factor receptor (EGFR)‐expressing xenograft breast cancer tissue in RAG2−/− mice.[228] To engineer EVs for EGFR‐expressing tumor targeting, Kooijmans et al.